Editorial: Emerging Biomarkers in Genitourinary Tumors
dc.contributor.author | Montironi, Rodolfo | |
dc.contributor.author | Santoni, Matteo | |
dc.contributor.author | Cimadamore, Alessia | |
dc.contributor.author | Lopez-Beltran, Antonio | |
dc.contributor.author | Cheng, Liang | |
dc.contributor.department | Pathology and Laboratory Medicine, School of Medicine | en_US |
dc.date.accessioned | 2019-08-21T14:24:22Z | |
dc.date.available | 2019-08-21T14:24:22Z | |
dc.date.issued | 2019-04-26 | |
dc.identifier.citation | Montironi, R., Santoni, M., Cimadamore, A., Lopez-Beltran, A., & Cheng, L. (2019). Editorial: Emerging Biomarkers in Genitourinary Tumors. Frontiers in oncology, 9, 326. doi:10.3389/fonc.2019.00326 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/20458 | |
dc.language.iso | en_US | en_US |
dc.publisher | Frontiers | en_US |
dc.relation.isversionof | 10.3389/fonc.2019.00326 | en_US |
dc.relation.journal | Frontiers in Oncology | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.source | PMC | en_US |
dc.subject | PSMA | en_US |
dc.subject | Bladder cancer | en_US |
dc.subject | Genitourinary tumors | en_US |
dc.subject | Immunotherapy | en_US |
dc.subject | Liquid biopsy | en_US |
dc.subject | Microbiome | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | Renal cell carcinoma | en_US |
dc.title | Editorial: Emerging Biomarkers in Genitourinary Tumors | en_US |
dc.type | Article | en_US |